Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47382)
CDC/NIH Web Information Database (32170)
CDC-Authored Genomics and Precision Health Publications Database (5894)
Precision Health Database (63623)
Tier-Classified Guidelines Database (533)
Pathogen Advanced Molecular Detection Database (26729)
All of Us Reports and Publications Database (656)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226219)
Epigenetic Epidemiology Publications Database (22714)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Cancer
Last data update: Apr 18, 2024
. (Total: 63623 Documents since 2012)
All
Cancer
Diabetes
Economic
Equity
Environmental
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 93 Records)
Next
Query Trace:
Lung Cancer[original query]>>Evidence Synthesis [Product Type]
Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review.
Clare Meernik et al. J Natl Cancer Inst 2024
Similar articles in PubMed
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy.
Zakile A Mfumbilwa et al. Pharmacoeconomics 2024
Similar articles in PubMed
Genomic landscape and actionable mutations of brain metastases derived from non-small cell lung cancer: A systematic review.
Lily J Andrews et al. Neurooncol Adv 2023 5(1) vdad145
Similar articles in PubMed
Cost-Effectiveness of Comprehensive Genomic Profiling in Patients With Non-Small Cell Lung Cancer for the Colombian Health System.
Oscar Gamboa et al. Value Health Reg Issues 2023 39115-125
Similar articles in PubMed
Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis.
Cheng Chen et al. medRxiv 2023
Similar articles in PubMed
The health inequality impact of liquid biopsy to inform first-line treatment of advanced non-small cell lung cancer - a distributional cost-effectiveness analysis.
Jeroen P Jansen et al. Value Health 2023
Similar articles in PubMed
Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of EGFR Mutation in Advanced Non-Small Cell Lung Cancer.
Sun Mi Cho et al. Ann Lab Med 2023 43(6) 605-613
Similar articles in PubMed
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature.
Laura Evangelista et al. Cancers (Basel) 2023 15(12)
Similar articles in PubMed
Predicting EGFR Mutation Status in Non-Small Cell Lung Cancer Using Artificial Intelligence: A Systematic Review and Meta-Analysis.
Hung Song Nguyen et al. Acad Radiol 2023
Similar articles in PubMed
Polymorphisms in VDR, CYP27B1, CYP2R1, GC and CYP24A1 Genes as Biomarkers of Survival in Non-Small Cell Lung Cancer: A Systematic Review.
Laura Elena Pineda-Lancheros et al. Nutrients 2023 15(6)
Similar articles in PubMed
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.
Edurne Arriola et al. JCO precision oncology 2023 7e2200546
Similar articles in PubMed
Budget Impact Analysis of Comprehensive Genomic Profiling in Advanced Non-Small Cell Lung Cancer in Taiwan.
Yi-Ling Tsai et al. Value in health regional issues 2023 3548-56
Similar articles in PubMed
Cost-effectiveness of camrelizumab plus chemotherapy vs. chemotherapy in the first-line treatment of non-squamous NSCLC: Evidence from China.
Hongbin Dai et al. Frontiers in medicine 2023 101122731
Similar articles in PubMed
Association of Reported Candidate Monogenic Genes With Lung Cancer Risk.
Andrew S Rifkin et al. Clinical lung cancer 2023
Similar articles in PubMed
Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United States.
Lemmon Christopher A et al. JCO precision oncology 2023 7e2200294
Similar articles in PubMed
Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography.
Mikhael Peter G et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 JCO2201345
Similar articles in PubMed
Diagnostic test accuracy of artificial intelligence-based imaging for lung cancer screening: A systematic review and meta-analysis.
Thong Lay Teng et al. Lung cancer (Amsterdam, Netherlands) 2022 1764-13
Similar articles in PubMed
The budget impact of introducing mobocertinib for the postplatinum treatment of advanced non-small cell lung cancer harboring epidermal growth factor receptor exon 20 insertion mutations.
Hernandez Luis et al. Journal of managed care & specialty pharmacy 2022 1-15
Similar articles in PubMed
Multiple mutations in the EGFR gene in lung cancer: a systematic review.
Castañeda-González Juan Pablo et al. Translational lung cancer research 2022 11(10) 2148-2163
Similar articles in PubMed
Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis.
Palmieri Maria et al. Frontiers in genetics 2022 131015161
Similar articles in PubMed
Reclassification of risk of malignancy with Percepta Genomic Sequencing Classifier following nondiagnostic bronchoscopy.
Raval Abhijit A et al. Respiratory medicine 2022 204106990
Similar articles in PubMed
The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analysis of randomized clinical trials.
Wang Bi-Cheng et al. PloS one 2022 17(10) e0275919
Similar articles in PubMed
Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer.
Simons Martijn J H G et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2022
Similar articles in PubMed
The Cost-Effectiveness of Tislelizumab Plus Chemotherapy for Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer.
Luo Xia et al. Frontiers in pharmacology 2022 13935581
Similar articles in PubMed
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.
Ezeife Doreen A et al. Therapeutic advances in medical oncology 2022 1417588359221112696
Similar articles in PubMed
Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the Netherlands.
Wolff Henri B et al. JCO precision oncology 2022 6e2200201
Similar articles in PubMed
Diagnostic Value and Cost-effectiveness of Next Generation Sequencing-based Testing for Treatment of Patients with Advanced/Metastatic Non-squamous Non-small Cell Lung Cancer in the US.
Zou Denise et al. The Journal of molecular diagnostics : JMD 2022
Similar articles in PubMed
IPRS: Leveraging Gene-Environment Interaction to Reconstruct Polygenic Risk Score.
Tang Yingdan et al. Frontiers in genetics 2022 13801397
Similar articles in PubMed
Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer.
Vanderpoel Julie et al. Journal of medical economics 2022 1-17
Similar articles in PubMed
Computer-aided detection of pulmonary nodules based on convolutional neural networks: a review.
Min Yuqin et al. Physics in medicine and biology 2022
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 18, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP